Insider · CIK 0001927975
William A. Wexler
Files at ERNA (Eterna Therapeutics Inc.), CMRA (Comera Life Sciences Holdings, Inc.). First filing -, latest -.
In brief
William A. Wexler files SEC Form 4 as director at ERNA (Eterna Therapeutics Inc.), and also at CMRA (Comera Life Sciences Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; William A. Wexler has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | ERNA Eterna Therapeutics Inc. | AGrant or award Stock Option (Right to buy)derivative | +5,943 | $0.00 | $0 | 5,943 | 42 d ago |
| Feb 7, 2025 | ERNA Eterna Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +124,533 | $0.00 | $0 | 124,533 | Feb 10, 2025 |
| Nov 15, 2023 | CMRA Comera Life Sciences Holdings, Inc. | JOther Common Stock | +3,113 | $0.00 | $0 | 20,811 | Nov 17, 2023 |
| Nov 9, 2023 | CMRA Comera Life Sciences Holdings, Inc. | AGrant or award Stock Option (Right to Purchase)derivative | +75,376 | $0.00 | $0 | 75,376 | Nov 14, 2023 |
Questions about William A. Wexler
Answered from the filings on this page, as of the latest one.
Is William A. Wexler buying or selling?
William A. Wexler has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did William A. Wexler's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and William A. Wexler has 0.
Where does William A. Wexler file Form 4?
William A. Wexler has filed Form 4 at ERNA (Eterna Therapeutics Inc.); CMRA (Comera Life Sciences Holdings, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.